3-[(1-ethyl-1H-1,3-benzodiazol-2-yl)amino]propan-1-ol, 95.0%, 1g

Methyl 3-amino-3-(4-nitrophenyl)propanoate, 95.0%, 5g

2-Morpholin-4-yl-isonicotinic acid, 95.0%, 100g

N-((4,6-dimethoxypyrimidin-2-yl)carbamoyl)-3-(trifluoromethyl)pyridine-2-sulfonamide, 98%, 250mg

2,2,2-Trifluoroacetamide, 99.0%, 1kg

Iron(II) gluconate dihydrate, min. 97%, pa, 250 g, plastic packaging.

Xphos Pd G4, ?98.0%, 1g

6-Chloro-N2-methylpyridine-2,3-diamine, 95.0%, 10g

2-(methylsulfanyl)ethanimidamide hydrochloride, 95.0%, 250mg

5-bromo-1-chloro-2-methyl-3-nitrobenzene, 97%, 250mg

TETRAHYDROPIPERINE, 95%, 250mg

Benzo[c][1,2,5]oxadiazol-5-ylboronic acid, 95.0%, 1g

1H-PYRROLO[3,2-B]PYRIDINE-1-CARBOXYLIC ACID, 2,3-DIHYDRO-, 1,1-DIMETHYLETHYL ESTER, 95.0%, 250mg